The Therapeutic Goods Administration approved more than 6,300 medicinal cannabis prescriptions in November, the highest total in 2020, according to the latest data.

Figures published by the TGA revealed 6,356 prescriptions were approved through the Special Access Scheme, beating the previous record of 6,206 in September.

Special Access Scheme approvals for the past 12 months

It brings the total number of SAS-B approvals in 2020 to 52,151.

In total, the TGA has now approved more than 80,000 SAS-B applications for unapproved medicinal cannabis products.

The number of Authorised Prescribers rose from 146 to 149 as at November 30.